Amplify Weight Loss Drug & Treatment ETF (THNR): ETF
ETF traded on ARCX under symbol THNR. Quoted in usd.
Amplify Weight Loss Drug & Treatment ETF
+0.67%$25.91
ARCX:THNREquity
AUM $5.15M·YTD --·Yield --
ARCX:THNR$25.91+0.67%AUM $5.15MTop Holdings
65.5% of portfolio in top 10 holdings
Concentrated in Healthcare (100.0%)
Performance:
 | LLY Eli Lilly & Co | +16.98% | 437 | |
 | NVO Novo Nordisk A/S | +7.41% | 11.1K | |
 | AMGN Amgen Inc | +14.36% | 684 | |
 | AZN AstraZeneca PLC | +17.54% | 1.6K | |
 | REGN Regeneron Pharmaceuticals Inc | +22.42% | 330 | |
 | GILD Gilead Sciences Inc | +15.71% | 1.8K | |
 | ROP.SW Roche Holding AG | -- | 613 | |
 | ABBV AbbVie Inc | +9.23% | 998 | |
 | PFE Pfizer Inc | +6.87% | 9.5K | |
 | 4519.T Chugai Pharmaceutical Co Ltd | -- | 6.0K | |
 | MRK Merck & Co Inc | +3.37% | 1.8K | |
 | 1093.HK CSPC Pharmaceutical Group Ltd | -- | 226.0K | |
 | 1801.HK Innovent Biologics Inc | -- | 21.0K | |
 | VKTX Viking Therapeutics Inc | -5.43% | 7.9K | |
 | ARWR Arrowhead Pharmaceuticals Inc | -5.49% | 3.1K | |
 | ZEAL.CO Zealand Pharma A/S | -- | 4.8K | |
 | 128940.KS Hanmi Pharm Co Ltd | -- | 477 | |
 | 1276.HK Jiangsu Hengrui Pharmaceuticals Co Ltd | -- | 18.8K | |
 | GPCR Structure Therapeutics Inc | -25.92% | 5.3K | |
 | KLRA Kailera Therapeutics Inc | +19.76% | 4.3K | |
 | AGPXX Invesco Government & Agency Portfolio 12/31/2031 | -- | 18.7K | |
Cash & Other Cash | -- | 16.8K |
Institutional Holders
Sector Breakdown
| Sector | Weight |
|---|---|
| Healthcare | 100.00% |
Holdings Treemap
Country Allocation
| Country | Weight |
|---|---|
| United States | 57.22% |
| Denmark | 12.08% |
| China | 11.03% |
| United Kingdom | 5.90% |
| Switzerland | 5.73% |
| Japan | 5.14% |
| South Korea | 2.89% |